Hereditary primary hemochromatosis is caused by a single faulty building block in a gene. This leads to iron overload, which can have serious consequences for organs and joints. In preclinical studies, researchers have already successfully treated this genetic defect using a targeted correction technique known as base editing. They have now further refined their method in the laboratory.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Редактирование генов научились использовать для лечения болезни Паркинсона | 0 | 0 | 10-09-2019 |
| 2 | Разработана генная терапия от детской кардиомиопатии | 0 | 13.31 | 19-08-2026 |
| 3 | Cells use a little-known molecule to protect themselves from iron overload | 0 | 8.18 | 14-08-2026 |
| 4 | Роспотребнадзор разработал новый подход к генному лечению ВИЧ-инфекций | 0 | 0 | 11-11-2019 |
| 5 | Gene Therapy Cures Soccer-Loving Boy of Beta Thalassemia | 0 | 24.6 | 22-06-2026 |
| 6 | Molecular electromagnetic sensor may enable remote-controlled gene therapy | 0 | 9.75 | 17-08-2026 |
| 7 | Small-molecule switches put therapeutic CRISPR editing under on-demand control in living tissues | 5 | 7 | 03-07-2026 |
| 8 | Gene editing technology can help de-extinct some animals — but should it? | 0 | 7 | 03-07-2026 |
| 9 | Ученые США и России будут совместно развивать уникальную технологию редактирования генома | 0 | 0 | 22-11-2018 |
| 10 | Новый подход к редактированию эмбрионов расколол научный мир на два лагеря | 0 | 5 | 12-06-2026 |